Incyte (INCY) Down 5.4% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 03/14/20
Incyte Corporation (INCY) CEO Hervé Hoppenot on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 02/13/20
Eli Lilly and Incyte Record Another Positive Clinical Trial for Olumiant Works in EczemaThe Motley Fool • 02/12/20
Potential Lung Cancer Drug from Incyte and Novartis to Get a Priority Review from FDAThe Motley Fool • 02/11/20
Eli Lilly and Incyte's Olumiant Helps Eczema Patients in a Late-Stage Clinical TrialThe Motley Fool • 01/27/20